Factors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru

3Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. Methods An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. Results Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). Conclusions Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.

Cite

CITATION STYLE

APA

Soriano-Moreno, D. R., Fernandez-Guzman, D., Sangster-Carrasco, L., Quispe-Vicuña, C., Grados-Espinoza, P., Ccami-Bernal, F., … Nieto-Gutierrez, W. (2022). Factors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru. Journal of Patient Safety, 18(8), E1189–E1195. https://doi.org/10.1097/PTS.0000000000001053

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free